Monitoring

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GH
1 program
Continuous MonitoringN/A1 trial
Active Trials
NCT07309809Not Yet Recruiting50Est. Jul 2026
P
PhilipsNetherlands - Amsterdam
1 program
Wearable SensorN/A1 trial
Active Trials
NCT05181111Unknown800Est. Jul 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GE HealthCareContinuous Monitoring
PhilipsWearable Sensor

Clinical Trials (2)

Total enrollment: 850 patients across 2 trials

NCT07309809GE HealthCareContinuous Monitoring

Portrait Mobile Monitoring Solution V2.0 External Evaluation

Start: Mar 2026Est. completion: Jul 202650 patients
N/ANot Yet Recruiting
NCT05181111PhilipsWearable Sensor

Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways

Start: Dec 2021Est. completion: Jul 2023800 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space